MCKENZIE W THORPE 13D and 13G filings for XBiotech Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-27 2:39 pm Purchase |
2024-12-31 | 13G | XBiotech Inc. XBIT |
MCKENZIE W THORPE | 2,987,509 9.710% |
16,250 (+0.55%) |
Filing |
| 2024-02-07 12:01 pm Sale |
2023-12-31 | 13G | XBiotech Inc. XBIT |
MCKENZIE W THORPE | 2,971,259 9.680% |
-65,000 (-2.14%) |
Filing |
| 2023-02-10 12:21 pm Purchase |
2022-12-31 | 13G | XBiotech Inc. XBIT |
MCKENZIE W THORPE | 3,036,259 9.870% |
25,000 (+0.83%) |
Filing |
| 2022-02-15 6:59 pm Sale |
2021-12-31 | 13G | XBiotech Inc. XBIT |
MCKENZIE W THORPE | 3,011,259 9.810% |
-1,931,080 (-39.07%) |
Filing |